CAMBRIDGE, Mass.--(BUSINESS WIRE)--May. 14, 2009--
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by Deutsche Bank on Monday, May 18,
2009, at 9:20 a.m. ET. The presentation will be webcast from the
InterContinental Hotel in Boston and may be accessed under the investor
relations tab at www.alkermes.com.
The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL® for
alcohol dependence and manufactures RISPERDAL® CONSTA®
for schizophrenia. Alkermes' robust pipeline includes extended-release
injectable, pulmonary and oral products for the treatment of prevalent,
chronic diseases, such as central nervous system disorders, addiction
and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has
research facilities in Massachusetts and a commercial manufacturing
facility in Ohio.
Source: Alkermes, Inc.
Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Corporate
Communications
